Skip to main content

Month: September 2023

Stack Capital Holding Hopper Announces Strategic Partnerships With Hotelbeds & WebBeds

Hopper customers and its B2B partners gain access to 700,000+ hotel properties worldwideSTACK CAPITAL HOLDING HOPPER ANNOUNCES STRATEGIC PARTNERSHIPS WITH HOTELBEDS & WEBBEDSHopper customers and its B2B partners gain access to 700,000+ hotel properties worldwideTORONTO, Sept. 28, 2023 (GLOBE NEWSWIRE) — Stack Capital Group Inc., (TSX:STCK and STCK.WT) is pleased to announce that Hopper, Inc. (“Hopper”), an existing portfolio holding, has entered into strategic partnerships with Hotelbeds, a global leader in the TravelTech space, and WebBeds, a global marketplace which provides powerful distribution solutions that make the buying and selling of travel products easier. As the third largest online travel agency in the United States, with 100+ million app downloads, these new partnerships allow Hopper to ‘super-charge’...

Continue reading

Intention to Make a Normal Course Issuer Bid for Subordinate Voting Shares and Preferred Shares

TORONTO, Sept. 28, 2023 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that the Toronto Stock Exchange (the “TSX”) has accepted a notice filed by Fairfax of its intention to commence a Normal Course Issuer Bid (“NCIB”) through the facilities of the TSX (or other alternative Canadian trading systems) for its Subordinate Voting Shares and the following series of its Preferred Shares: Cumulative 5-Year Rate Reset Preferred Shares, Series C (“Series C Shares”), Cumulative Floating Rate Preferred Shares, Series D (“Series D Shares”), Cumulative 5-Year Rate Reset Preferred Shares, Series E (“Series E Shares”), Cumulative Floating Rate Preferred Shares, Series F (“Series F Shares”), Cumulative 5-Year Rate Reset Preferred Shares, Series G (“Series G Shares”), Cumulative Floating Rate Preferred...

Continue reading

Draganfly Announces Participation in the LD Micro Main Event XVI and Company Receives Minimum Bid Notification

Los Angeles, CA., Sept. 28, 2023 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, announced today that it will be presenting at the 16th annual LD Micro Main Event at the Luxe Sunset Boulevard Hotel, Los Angeles, California from October 3 to 5, 2023. More than 200 attendees are expected to attend the 16th annual LD Micro Main Event, comprising industry professionals, investors, and entrepreneurs seeking opportunities for growth and collaboration. This platform enables participating companies to present their innovative offerings and connect with like-minded individuals to explore potential avenues for expansion. Draganfly President and CEO Cameron Chell will present on October 3rd, 1 pm PST. We invite...

Continue reading

Renalytix Reports Full Year Fiscal 2023 Results

LONDON and SALT LAKE CITY, Sept. 28, 2023 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, reports its financial results for the fiscal year ended June 30, 2023. Recent Highlights (including post period events) Regulatory & ReimbursementAchieved FDA De Novo marketing authorization for KidneyIntelX.dkd to assess risk of progressive kidney function decline in adults with diabetes and early-stage kidney disease. Secured additional key insurance coverage contracts for KidneyIntelX including:EmblemHealth, covering over three million lives in New York Tri-state region CareFirst BlueCross BlueShield, the largest health care plan...

Continue reading

Karolinska Development’s portfolio company PharmNovo reports promising preclinical results on abuse potential and withdrawal symptom relief for its candidate drug PN6047

STOCKHOLM, SWEDEN, September 28, 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company PharmNovo has reported promising results in a preclinical study of the company’s drug candidate PN6047. The results reaffirm existing safety profile data of PN6047, which is planned to enter clinical phase 2 trials in 2024. PharmNovo is developing a novel treatment for nerve pain, a difficult-to-treat form of pain that often develops into a chronic condition. The company’s drug candidate PN6047 is a novel candidate drug that was spun off from cutting-edge research at AstraZeneca and is currently being evaluated in a clinical phase 1 study. These new preclinical results show that the drug candidate does not induce drug abuse behavior in non-clinical test models and indicates the capacity to reduce opioid withdrawal...

Continue reading

Notice to the BBS-Bioactive Bone Substitutes Plc’s Extraordinary General Meeting

BBS-Bioactive Bone Substitutes Plc, Company Announcement, 28 September 2023 at 2.20 pm (EET) Notice to the BBS-Bioactive Bone Substitutes Plc’s Extraordinary General Meeting The shareholders of BBS-Bioactive Bone Substitutes Plc are invited to the company’s Extraordinary General Meeting (EGM), which is held at the company’s premises at Kiviharjunlenkki 6, 90220 Oulu, on Monday 23 October 2023 starting at 2.00 pm (EET). The right to attend will be on each shareholder who, on the record date of 11 October 2023, is registered in the company’s shareholder register. The shareholders of nominee-registered shareholder are entitled to attend on the basis of the shares entitling him/her to be registered in the Shareholder Register on 20 October 2023 at 10.00 am. A. MATTERS TO BE DEALT WITH AT THE EGM 1. Opening of the EGM 2. Election of the chairman...

Continue reading

Northland Power Announces Financial Close of the 1.0 GW Hai Long Offshore Wind Project in Taiwan Financing and Date for Investor Presentation Conference Call

TORONTO, Sept. 28, 2023 (GLOBE NEWSWIRE) — Northland Power Inc. (Northland) (TSX: NPI) today announced that its Hai Long offshore wind project (Hai Long or the project) in Taiwan has successfully met all conditions to close its 1171 billion New Taiwan Dollars long-term non-recourse green financing (equivalent of CAD 5 billion). The non-recourse green project financing will be provided by over 15 international and local lenders with support from multiple Export Credit Agencies (ECAs) including: Export Development Canada (EDC), Japan Bank for International Cooperation (JBIC), Nippon Export and Investment Insurance (NEXI), UK Export Finance (UKEF), Export Finance Australia (EFA), Export Finance Norway (Eksfin) and Credendo – Export Credit Agency of Belgium. Hai Long will play an important role in helping the Government of Taiwan achieve...

Continue reading

TAAT® Global Alternatives Inc. Announces Share Consolidation

LAS VEGAS and VANCOUVER, British Columbia, Sept. 28, 2023 (GLOBE NEWSWIRE) — TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT®”) announces that, pursuant to directors’ resolutions, the Company will be consolidating all of its issued and outstanding share capital (the “Common Shares”) on the basis of every ten (10) old Common Shares into one (1) new Common Share (the “Share Consolidation”), effective October 3, 2023 (the “Record Date”). As a result of the Share Consolidation, the issued and outstanding Common Shares will be reduced to approximately 11,556,246. No fractional shares will be issued as a result of the Share Consolidation. All fractions of Common Shares will be rounded down to the next lowest whole number. No cash consideration will be paid in respect of fractional shares....

Continue reading

Lands’ End Celebrates 40 Years of the Iconic Squall® Jacket With a Limited-Edition 1963 Collection

Exclusively available at LandsEnd.com to celebrate the brand’s 60th anniversaryLands’ End60 years of Lands’ End®, 40 years of Squall®DODGEVILLE, Wis., Sept. 28, 2023 (GLOBE NEWSWIRE) — Lands’ End, the classic American lifestyle brand, honors 40 years of its iconic Squall® Jacket by launching a limited-edition 1963 design. The collection includes five exclusive Squall® styles which incorporate designs that pay tribute to the brand’s quintessential heritage.   In celebration of 60 years, the newly launched 1963 collection highlights timeless silhouettes with pops of color and unique detailing such as four nautical signal flags adorning the waist flap of the anorak and signal flags on the crewneck sweater to read LE63. For decades, Squall® has been a staple in wardrobes, serving as a trusted companion for outdoor...

Continue reading

Form 8.3 – [EMIS Group plc – 27 09 2023] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree EMIS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.